Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2009 Dec 29;10652:22211-6. doi: 10.1073/pnas.0910123106.
Show Gene links
Show Anatomy links
A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library.
Takacs Z
,
Toups M
,
Kollewe A
,
Johnson E
,
Cuello LG
,
Driessens G
,
Biancalana M
,
Koide A
,
Ponte CG
,
Perozo E
,
Gajewski TF
,
Suarez-Kurtz G
,
Koide S
,
Goldstein SA
.
???displayArticle.abstract???
Venomous animals immobilize prey using protein toxins that act on ion channels and other targets of biological importance. Broad use of toxins for biomedical research, diagnosis, and therapy has been limited by inadequate target discrimination, for example, among ion channel subtypes. Here, a synthetic toxin is produced by a new strategy to be specific for human Kv1.3 channels, critical regulators of immune T cells. A phage display library of 11,200 de novo proteins is designed using the alpha-KTx scaffold of 31 scorpion toxin sequences known or predicted to bind to potassium channels. Mokatoxin-1 (moka1) is isolated by affinity selection on purified target. Moka1 blocks Kv1.3 at nanomolar levels that do not inhibit Kv1.1, Kv1.2, or KCa1.1. As a result, moka1 suppresses CD3/28-induced cytokine secretion by T cells without cross-reactive gastrointestinal hyperactivity. The 3D structure of moka1 rationalizes its specificity and validates the engineering approach, revealing a unique interaction surface supported on an alpha-KTx scaffold. This scaffold-based/target-biased strategy overcomes many obstacles to production of selective toxins.
Abbas,
A new Kaliotoxin selective towards Kv1.3 and Kv1.2 but not Kv1.1 channels expressed in oocytes.
2008, Pubmed,
Xenbase
Abbas,
A new Kaliotoxin selective towards Kv1.3 and Kv1.2 but not Kv1.1 channels expressed in oocytes.
2008,
Pubmed
,
Xenbase
Beeton,
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases.
2006,
Pubmed
Beeton,
Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation.
2001,
Pubmed
Cornilescu,
Protein backbone angle restraints from searching a database for chemical shift and sequence homology.
1999,
Pubmed
Cortes,
Structural dynamics of the Streptomyces lividans K+ channel (SKC1): oligomeric stoichiometry and stability.
1997,
Pubmed
,
Xenbase
Crest,
Kaliotoxin, a novel peptidyl inhibitor of neuronal BK-type Ca(2+)-activated K+ channels characterized from Androctonus mauretanicus mauretanicus venom.
1992,
Pubmed
Delaglio,
NMRPipe: a multidimensional spectral processing system based on UNIX pipes.
1995,
Pubmed
Duda,
Evolutionary diversification of multigene families: allelic selection of toxins in predatory cone snails.
2000,
Pubmed
Fernández,
Kaliotoxin (1-37) shows structural differences with related potassium channel blockers.
1994,
Pubmed
Garcia,
Purification and characterization of three inhibitors of voltage-dependent K+ channels from Leiurus quinquestriatus var. hebraeus venom.
1994,
Pubmed
,
Xenbase
Giangiacomo,
Revealing the molecular determinants of neurotoxin specificity for calcium-activated versus voltage-dependent potassium channels.
2007,
Pubmed
Goldstein,
The charybdotoxin receptor of a Shaker K+ channel: peptide and channel residues mediating molecular recognition.
1994,
Pubmed
,
Xenbase
Goldstein,
Mechanism of charybdotoxin block of a voltage-gated K+ channel.
1993,
Pubmed
,
Xenbase
Grissmer,
Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
1994,
Pubmed
Güntert,
Automated NMR structure calculation with CYANA.
2004,
Pubmed
Han,
Structural basis of a potent peptide inhibitor designed for Kv1.3 channel, a therapeutic target of autoimmune disease.
2008,
Pubmed
Johnson,
NMR View: A computer program for the visualization and analysis of NMR data.
1994,
Pubmed
Koo,
Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo.
1997,
Pubmed
Legros,
Engineering-specific pharmacological binding sites for peptidyl inhibitors of potassium channels into KcsA.
2002,
Pubmed
Legros,
Generating a high affinity scorpion toxin receptor in KcsA-Kv1.3 chimeric potassium channels.
2000,
Pubmed
Leonard,
Selective blockers of voltage-gated K+ channels depolarize human T lymphocytes: mechanism of the antiproliferative effect of charybdotoxin.
1992,
Pubmed
Lewis,
Therapeutic potential of venom peptides.
2003,
Pubmed
Li,
Use of phage display to probe the evolution of binding specificity and affinity in integrins.
2003,
Pubmed
Li,
Use of a modified bacteriophage to probe the interactions between peptides and ion channel receptors in mammalian cells.
1997,
Pubmed
Meki,
KTX3, the kaliotoxin from Buthus occitanus tunetanus scorpion venom: one of an extensive family of peptidyl ligands of potassium channels.
2000,
Pubmed
Miller,
Charybdotoxin, a protein inhibitor of single Ca2+-activated K+ channels from mammalian skeletal muscle.
,
Pubmed
Miller,
The charybdotoxin family of K+ channel-blocking peptides.
1995,
Pubmed
Olamendi-Portugal,
Novel alpha-KTx peptides from the venom of the scorpion Centruroides elegans selectively blockade Kv1.3 over IKCa1 K+ channels of T cells.
2005,
Pubmed
Olivera,
Diversity of the neurotoxic Conus peptides: a model for concerted pharmacological discovery.
2007,
Pubmed
Park,
Design, synthesis, and functional expression of a gene for charybdotoxin, a peptide blocker of K+ channels.
1991,
Pubmed
Pennington,
Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytes.
2009,
Pubmed
Price,
Charybdotoxin inhibits proliferation and interleukin 2 production in human peripheral blood lymphocytes.
1989,
Pubmed
Rajan,
Sumoylation silences the plasma membrane leak K+ channel K2P1.
2005,
Pubmed
,
Xenbase
Ramu,
Engineered specific and high-affinity inhibitor for a subtype of inward-rectifier K+ channels.
2008,
Pubmed
,
Xenbase
Ranganathan,
Spatial localization of the K+ channel selectivity filter by mutant cycle-based structure analysis.
1996,
Pubmed
Roberts,
Directed evolution of a protein: selection of potent neutrophil elastase inhibitors displayed on M13 fusion phage.
1992,
Pubmed
Rodríguez de la Vega,
Current views on scorpion toxins specific for K+-channels.
2004,
Pubmed
Schnölzer,
In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences.
1992,
Pubmed
Sidhu,
Phage display for engineering and analyzing protein interaction interfaces.
2007,
Pubmed
Smith,
Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface.
1985,
Pubmed
Stampe,
Intimations of K+ channel structure from a complete functional map of the molecular surface of charybdotoxin.
1994,
Pubmed
Suarez-Kurtz,
Peptidyl inhibitors of shaker-type Kv1 channels elicit twitches in guinea pig ileum by blocking kv1.1 at enteric nervous system and enhancing acetylcholine release.
1999,
Pubmed
Takacs,
Cobra ( Naja spp. ) nicotinic acetylcholine receptor exhibits resistance to Erabu sea snake ( Laticauda semifasciata) short-chain alpha-neurotoxin.
2004,
Pubmed
,
Xenbase
Vianna-Jorge,
Shaker-type Kv1 channel blockers increase the peristaltic activity of guinea-pig ileum by stimulating acetylcholine and tachykinins release by the enteric nervous system.
2003,
Pubmed
